Xin Tan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xin Tan has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
Linjie Wu
Zhejiang University
3 shared publicationsQi Dai
Zhejiang University
3 shared publications- Ruolin Jiang
Zhejiang University
3 shared publications Xiaoyan Bao
Zhejiang University
3 shared publicationsXiaoyan Sun
Zhejiang University
3 shared publicationsYaxin Qin
Zhejiang University
3 shared publications
Latest Publications
- 9 November 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
Correction to “Self-Healing Hydrogel Resulting from the Noncovalent Interaction between Ropivacaine and Low-Molecular-Weight Gelator Sodium Deoxycholate Achieves Stable and Endurable Local Analgesia In Vivo”
- 9 November 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
Correction to “Self-Healing Hydrogel Resulting from the Noncovalent Interaction between Ropivacaine and Low-Molecular-Weight Gelator Sodium Deoxycholate Achieves Stable and Endurable Local Analgesia In Vivo”
- 6 September 2025
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 17 (37) , 52474-52487
Dual-Functional Nanoliposome with High BPA Loading for Targeted MRI-Guided BNCT of Glioblastoma
Glioblastoma is a highly malignant brain tumor with few available therapeutic options, for which boron neutron capture therapy (BNCT) has emerged as a promising precision radiotherapy approach. However, its efficacy remains suboptimal due to inadequate tumor targeting of boron agents and lack of in vivo visualization. Herein, a gadolinium-boron integrated lipid nanocarrier (BPA-F&DOTA-Gd@LIPO-ANG) was developed for targeted boron delivery and MRI-guided BNCT. BPA-F and DOTA-Gd were coloaded into lipid nanocarriers using a microfluidic system, with Angiopep-2 modification to enhance blood-brain barrier penetration and glioma targeting. Following cellular uptake, BPA-F&DOTA-Gd@LIPO-ANG effectively increased boron accumulation in glioma cells, inducing significant apoptosis and DNA damage upon neutron irradiation. Intravenously injected into orthotopic glioma model mice, BPA-F&DOTA-Gd@LIPO-ANG selectively accumulated in the tumor site, increasing tumor-to-normal tissue (T/N) and tumor-to-blood (T/B) ratios. Enhanced boron accumulation facilitated greater cytotoxic effects mediated by high-energy rays from the boron capture reaction, leading to significantly prolonged mice survival. In addition, in vitro and in vivo MRI validations confirmed its MRI visualization capability, meeting the demand for boron drug imaging for BNCT diagnosis and treatment integration. Overall, these results suggest that BPA-F&DOTA-Gd@LIPO-ANG is a promising targeted boron delivery system for MRI-guided BNCT in glioblastoma treatment.
- 6 September 2025
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 17 (37) , 52474-52487
Dual-Functional Nanoliposome with High BPA Loading for Targeted MRI-Guided BNCT of Glioblastoma
Glioblastoma is a highly malignant brain tumor with few available therapeutic options, for which boron neutron capture therapy (BNCT) has emerged as a promising precision radiotherapy approach. However, its efficacy remains suboptimal due to inadequate tumor targeting of boron agents and lack of in vivo visualization. Herein, a gadolinium-boron integrated lipid nanocarrier (BPA-F&DOTA-Gd@LIPO-ANG) was developed for targeted boron delivery and MRI-guided BNCT. BPA-F and DOTA-Gd were coloaded into lipid nanocarriers using a microfluidic system, with Angiopep-2 modification to enhance blood-brain barrier penetration and glioma targeting. Following cellular uptake, BPA-F&DOTA-Gd@LIPO-ANG effectively increased boron accumulation in glioma cells, inducing significant apoptosis and DNA damage upon neutron irradiation. Intravenously injected into orthotopic glioma model mice, BPA-F&DOTA-Gd@LIPO-ANG selectively accumulated in the tumor site, increasing tumor-to-normal tissue (T/N) and tumor-to-blood (T/B) ratios. Enhanced boron accumulation facilitated greater cytotoxic effects mediated by high-energy rays from the boron capture reaction, leading to significantly prolonged mice survival. In addition, in vitro and in vivo MRI validations confirmed its MRI visualization capability, meeting the demand for boron drug imaging for BNCT diagnosis and treatment integration. Overall, these results suggest that BPA-F&DOTA-Gd@LIPO-ANG is a promising targeted boron delivery system for MRI-guided BNCT in glioblastoma treatment.
- 22 August 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (35) , 45969-45988
Self-Healing Hydrogel Resulting from the Noncovalent Interaction between Ropivacaine and Low-Molecular-Weight Gelator Sodium Deoxycholate Achieves Stable and Endurable Local Analgesia in Vivo
Regional analgesia based on the local anesthetic ropivacaine plays a crucial role in postoperative pain management and recovery; however, the short duration of analgesia limits its clinical potential. Various drug delivery systems such as microparticles and lipid carriers have been used to prolong the analgesic effect, yet most of them are prone to abrupt release from the site of administration or have poor analgesic effects of less than 48 h, which fail to meet the needs of postoperative analgesia. In this study, a low-molecular-weight gelator sodium deoxycholate-based hydrogel loaded with ropivacaine (DC-ROP gel) was designed for long-acting analgesia. The noncovalent interaction between ropivacaine and sodium deoxycholate helps to improve the stability and sustained release performance of the gel. This internal drug-binding hydrogel also avoids experiencing the burst release effect commonly seen in polymer hydrogels previously reported for the slow release of local anesthetics. DC-ROP gel exhibited the dual advantages of self-healing after compression and long-term controlled release. In mice with inflammatory pain, DC-ROP gel achieved peripheral nerve block for more than 1 week after a single injection. Histological and blood biochemical analyses confirmed that the DC-ROP gel did not produce systemic toxicity, and cytotoxicity experiments demonstrated that the DC-ROP gel resulted in low irritation. These results suggest that DC-ROP gel provides a promising strategy for local anesthetics in long-term postoperative pain management, broadening the potential of bile salt-based low-molecular-weight hydrogels for drug delivery.
- 22 August 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (35) , 45969-45988
Self-Healing Hydrogel Resulting from the Noncovalent Interaction between Ropivacaine and Low-Molecular-Weight Gelator Sodium Deoxycholate Achieves Stable and Endurable Local Analgesia in Vivo
Regional analgesia based on the local anesthetic ropivacaine plays a crucial role in postoperative pain management and recovery; however, the short duration of analgesia limits its clinical potential. Various drug delivery systems such as microparticles and lipid carriers have been used to prolong the analgesic effect, yet most of them are prone to abrupt release from the site of administration or have poor analgesic effects of less than 48 h, which fail to meet the needs of postoperative analgesia. In this study, a low-molecular-weight gelator sodium deoxycholate-based hydrogel loaded with ropivacaine (DC-ROP gel) was designed for long-acting analgesia. The noncovalent interaction between ropivacaine and sodium deoxycholate helps to improve the stability and sustained release performance of the gel. This internal drug-binding hydrogel also avoids experiencing the burst release effect commonly seen in polymer hydrogels previously reported for the slow release of local anesthetics. DC-ROP gel exhibited the dual advantages of self-healing after compression and long-term controlled release. In mice with inflammatory pain, DC-ROP gel achieved peripheral nerve block for more than 1 week after a single injection. Histological and blood biochemical analyses confirmed that the DC-ROP gel did not produce systemic toxicity, and cytotoxicity experiments demonstrated that the DC-ROP gel resulted in low irritation. These results suggest that DC-ROP gel provides a promising strategy for local anesthetics in long-term postoperative pain management, broadening the potential of bile salt-based low-molecular-weight hydrogels for drug delivery.
- 26 July 2022
- Published by SPIE-Intl Soc Optical Eng
- Vol. 12278, 47-191
Wavelength switchable mode-locked fiber laser using optical switch
Programmable and fast wavelength-switchable ultrashort pulses have important applications in optical communication, optical sensing, micro-wave photonics, and other fields. Multi-wavelength mode-locked lasers are commonly developed to achieve wavelength tunability by using tunable optical filters, fiber Bragg gratings, Lyot filters providing the direct spectral manipulation of the pulses. Actually, manual control is essential in process of wavelength switching, which is very time-consuming and sometimes it is difficult to find the appropriate state of polarization for a certain mode-locking state when utilizing polarization adjustment. So a programmable mode-locked laser which can automatically switch to different mode-locking states is desired. Here, we demonstrate a fast electrically-controlled wavelength-switching scheme in ultrafast nonlinear polarization rotation mode-locked lasers. It is achieved by simply introducing an inline polarization beam splitter (PBS) with two output ports and followed by a 1×2 electrically-controlled optical switch in a fiber ring laser. By utilizing the polarization-maintaining-fiber-pigtailed inline PBS and a polarization controller, a nonlinear polarization evolution (NPE) mode-locking effect as well as a tunable Lyot filter are enabled in the fiber cavity. The optical switch could select the optical path with different polarization state for mode-locking at different wavelength.
- 26 July 2022
- Published by SPIE-Intl Soc Optical Eng
- Vol. 12278, 47-191
Wavelength switchable mode-locked fiber laser using optical switch
Programmable and fast wavelength-switchable ultrashort pulses have important applications in optical communication, optical sensing, micro-wave photonics, and other fields. Multi-wavelength mode-locked lasers are commonly developed to achieve wavelength tunability by using tunable optical filters, fiber Bragg gratings, Lyot filters providing the direct spectral manipulation of the pulses. Actually, manual control is essential in process of wavelength switching, which is very time-consuming and sometimes it is difficult to find the appropriate state of polarization for a certain mode-locking state when utilizing polarization adjustment. So a programmable mode-locked laser which can automatically switch to different mode-locking states is desired. Here, we demonstrate a fast electrically-controlled wavelength-switching scheme in ultrafast nonlinear polarization rotation mode-locked lasers. It is achieved by simply introducing an inline polarization beam splitter (PBS) with two output ports and followed by a 1×2 electrically-controlled optical switch in a fiber ring laser. By utilizing the polarization-maintaining-fiber-pigtailed inline PBS and a polarization controller, a nonlinear polarization evolution (NPE) mode-locking effect as well as a tunable Lyot filter are enabled in the fiber cavity. The optical switch could select the optical path with different polarization state for mode-locking at different wavelength.
- Open Access
- 2 May 2021
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 22 (1) , 1-12
Overexpression of ING3 is associated with attenuation of migration and invasion in breast cancer
Inhibitor of growth 3 (ING3) has been identified as a potential cancer drug target, but little is known about its role in breast cancer. Thus, the present study aimed to investigate ING3 expression in breast cancer, its clinical value, and how ING3 influences the migration and invasion of breast cancer cells. The Cancer Genome Atlas and UALCAN databases were used to analyze ING3 expression in cancer tissues and normal tissues. Survival analysis was performed using the UALCAN, UCSC Xena and KM‑plot databases. In addition, reverse transcription‑quantitative PCR and western blot analyses were performed to detect ING3 mRNA and protein expression levels. ING3 was overexpressed via lentiviral vector transfection, while the Transwell and wound healing assays were performed to assess the cell migratory and invasive abilities. Protein interaction and pathway analyses were performed using the GeneMANIA and Kyoto Encyclopedia of Genes and Genomes databases, respectively. The results demonstrated that ING3 expression was significantly lower in cancer tissues compared with normal tissues (PING3 compared with normal breast tissues. Notably, statistically significant differences were observed in long‑term survival between patients with luminal A (P=0.04) and HER2‑enriched (P=0.008) breast cancer, with high and low expression levels of ING3. The results of the Transwell migration and invasion assays demonstrated that overexpression of ING3 significantly inhibited the migratory and invasive abilities of MCF7 (Pin vitro. However, further studies are required to determine whether ING3 regulates the biological behavior of breast cancer via tumor‑related pathways.
- 2 May 2021
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 22 (1) , 1-12
Open AccessOverexpression of ING3 is associated with attenuation of migration and invasion in breast cancer
Inhibitor of growth 3 (ING3) has been identified as a potential cancer drug target, but little is known about its role in breast cancer. Thus, the present study aimed to investigate ING3 expression in breast cancer, its clinical value, and how ING3 influences the migration and invasion of breast cancer cells. The Cancer Genome Atlas and UALCAN databases were used to analyze ING3 expression in cancer tissues and normal tissues. Survival analysis was performed using the UALCAN, UCSC Xena and KM‑plot databases. In addition, reverse transcription‑quantitative PCR and western blot analyses were performed to detect ING3 mRNA and protein expression levels. ING3 was overexpressed via lentiviral vector transfection, while the Transwell and wound healing assays were performed to assess the cell migratory and invasive abilities. Protein interaction and pathway analyses were performed using the GeneMANIA and Kyoto Encyclopedia of Genes and Genomes databases, respectively. The results demonstrated that ING3 expression was significantly lower in cancer tissues compared with normal tissues (PING3 compared with normal breast tissues. Notably, statistically significant differences were observed in long‑term survival between patients with luminal A (P=0.04) and HER2‑enriched (P=0.008) breast cancer, with high and low expression levels of ING3. The results of the Transwell migration and invasion assays demonstrated that overexpression of ING3 significantly inhibited the migratory and invasive abilities of MCF7 (Pin vitro. However, further studies are required to determine whether ING3 regulates the biological behavior of breast cancer via tumor‑related pathways.